The Cancer Prevention and Control Program at Naef K. Basile Cancer Institute (NKBCI) and The Cancer Support Fund at AUBMC in collaboration with The Global Health Institute are pleased to invite you to The Lighting Ceremony of the Saab Medical Library (SML) Building on February 3rd at 6:30pm.
Follow the event streamed online at the link below!
For front-line health practitioners working in conflict settings: Apply for the GHI’s Center for Research & Education in the Ecology of War #CREEW research fellowship.
Low- and Middle-Income Countries (LMICs) disproportionately shoulder the devastating effects of cancer: an imbalance glaringly evident in fragile and conflict-affected settings, prevalent in the Middle East and North Africa (MENA) region.
People with cancer have a higher risk of severe COVID-19. Getting the necessary initial vaccination against covid-19 followed by a BOOSTER 3rd dose shot is HIGHLY RECOMMENDED
The Covid-19 and Cancer Taskforce, a global group of cancer leaders undertook a rapid assessment of the COVID-19 vaccines’ current global availability and strategies for covering cancer patients + healthcare workers.
Surveying 38 countries from low to high-income with 33 countries responding.
The NKBCI actively promotes the development and dissemination of information resources on cancer prevention, management, and treatment as well as COVID-19 response for cancer patients.
Click the link below for more information:
NKBCI: AN INSTITUTE FOCUSED ON ALL ASPECTS OF DISEASE
CLINICAL EXPERTISE IN HEMATOLOGY ONCOLOGY
NEWLY ESTABLISHED ONCO-FERTILITY PROGRAM
THE CANCER SUPPORT FUND
NEWLY ESTABLISHED PSYCHO-ONCOLOGY PROGRAM
WELCOME TO THE NAEF K. BASILE CANCER
The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center (AUBMC) is a state-of-the-art adult cancer facility providing comprehensive cancer treatment and research.
The Institute was established through the generous contribution of the Naef K. Basile Foundation. The late Lebanese-American physician’s lifelong wish was to give back to his country of birth, founding an institute that would compare with the best cancer centers in the world.
The NKBCI relies on multidisciplinary specialized teams to diagnose and treat cancer and fosters health education programs to raise awareness on cancer prevention and early diagnosis.
COVID-19 PANDEMIC RESPONSE
COVID-19 VACCINATION + BOOSTERS FOR CANCER PATIENTS AND SURVIVORS
Vaccination for cancer patients under treatment and survivors followed by BOOSTER shots is HIGHLY RECOMMENDED. Click on this link to complete your registration on the MOPH vaccination platform.
Consult our specialists for more information on COVID-19 vaccination BOOSTER shots. Vaccination booster shots are recommended for cancer patients 4 months after receiving the second dose.
Anyone 12 years or older is eligible to receive a 3rd and 4th BOOSTER dose at AUBMC provided the 2nd dose was taken 4 months prior.
NKBCI TAKES PART IN THE COVID19 GLOBAL CANCER TASKFORCE
The Covid-19 and Cancer Taskforce is a globally representative group of cancer leaders spanning cancer disciplines from prevention, early detection, treatment, and palliative care, to cancer center networks and advocacy groups.
The expertise of the global cancer community will be drawn on with the aim to:
- Assess the immediate impacts on cancer patients
- Address risks for longer-term impacts on cancer outcomes
- Develop an integrated approach to build resilient cancer services
INFORMATION RESOURCES ON COVID-19 PRODUCED AT THE NKBCI
SCHEDULE AN ONLINE CONSULTATION WITH A HEMATOLOGY ONCOLOGY SPECIALIST
Learn how to schedule an online visit through MyAUBHealth or contact the call center directly on 01- 759 618.
MESSAGE FROM THE DIRECTOR
The NKBCI is an exciting and growing institute with leading clinicians, educators, and scientists working together to improve patient care. Our faculty participates in a full-range of academic activities that includes basic science research, clinical research, and teaching. We aspire to be a reference in medical care, leading innovation in the treatment of cancer in Lebanon and the region.
Ali Taher, MD, Ph.D., FRCP
BONE MARROW TRANSPLANTATION PROGRAM